Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:

Details Of Insider Trading Activities
TransactionCompanyTickerInsiderShares TradedAvg.
Price
Total ValueFiling
2020-06-29
Purchase
Adaptimmune Therapeutics PLCADAPWood Gavin
Chief Financial Officer
33,000$1.62$53,460
2020-06-09
Purchase
Adaptimmune Therapeutics PLCADAPAlleva Lawrence M
Director
12,900$1.89$24,381
2020-05-29
Sale
Adaptimmune Therapeutics PLCADAPNoble James
Director
500,000$9.33$4,665,000
2020-01-24
Purchase
Adaptimmune Therapeutics PLCADAPBASKETT FOREST
10% owner
7,500,000$0.67$5,025,000
2020-01-24
Purchase
Adaptimmune Therapeutics PLCADAPBehbahani Ali
Director
7,500,000$0.67$5,025,000
2020-01-24
Purchase
Adaptimmune Therapeutics PLCADAPFlorence Anthony A. Jr.
10% owner
7,500,000$0.67$5,025,000
2020-01-24
Purchase
Adaptimmune Therapeutics PLCADAPMOTT DAVID M
Director, 10% owner
7,500,000$0.67$5,025,000
2020-01-24
Purchase
Adaptimmune Therapeutics PLCADAPSANDELL SCOTT D
10% owner
7,500,000$0.67$5,025,000
2020-01-24
Purchase
Adaptimmune Therapeutics PLCADAPSonsini Peter W.
10% owner
7,500,000$0.67$5,025,000
2020-01-14
Sale
Adaptimmune Therapeutics PLCADAPRawcliffe Adrian
Chief Executive Officer, Director
3,236$5.13$16,600
2020-01-14
Sale
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,144$5.13$5,868
2020-01-14
Sale
Adaptimmune Therapeutics PLCADAPBertrand William C JR
Chief Operating Officer
2,397$5.13$12,296
2020-01-14
Sale
Adaptimmune Therapeutics PLCADAPNorry Elliot
Chief Medical Officer
911$5.13$4,673
2020-01-13
Sale
Adaptimmune Therapeutics PLCADAPNoble James
Director
300,000$4.67$1,401,000
2020-01-13
Sale
Adaptimmune Therapeutics PLCADAPTAYTON-MARTIN HELEN KATRINA
Chief Business Officer
100,000$4.50$450,000
2020-01-06
Sale
Adaptimmune Therapeutics PLCADAPRawcliffe Adrian
Chief Executive Officer, Director
5,900$1.20$7,080
2020-01-06
Sale
Adaptimmune Therapeutics PLCADAPBertrand William C JR
Chief Operating Officer
3,731$1.20$4,477
2020-01-06
Sale
Adaptimmune Therapeutics PLCADAPLunger John
Chief Patient Supply Officer
1,148$1.20$1,377
2019-08-06
Sale
Adaptimmune Therapeutics PLCADAPAmado Rafael
President, R&D
11,043$2.06$22,748
2019-01-14
Sale
Adaptimmune Therapeutics PLCADAPRawcliffe Adrian
Chief Financial Officer
3,084$5.37$16,561
2019-01-14
Sale
Adaptimmune Therapeutics PLCADAPAmado Rafael
President, R & D
3,028$5.37$16,260
2019-01-14
Sale
Adaptimmune Therapeutics PLCADAPBertrand William C JR
Chief Operating Officer
2,271$5.37$12,195
2019-01-14
Sale
Adaptimmune Therapeutics PLCADAPBinder-Scholl Gwendolyn Knowlton
Chief Technology Officer
1,514$5.37$8,130
2018-12-17
Purchase
Adaptimmune Therapeutics PLCADAPAlleva Lawrence M
Director
47,280$0.84$39,715
2018-10-01
Sale
Adaptimmune Therapeutics PLCADAPBinder-Scholl Gwendolyn Knowlton
Chief Technology Officer
25,000$13.79$344,750
2018-09-07
Purchase
Adaptimmune Therapeutics PLCADAPNew Enterprise Associates 14, L.P.
10% owner
3,000,000$1.67$5,010,000
2018-09-07
Purchase
Adaptimmune Therapeutics PLCADAPBARRETT M JAMES
10% owner
3,000,000$1.67$5,010,000
2018-09-07
Purchase
Adaptimmune Therapeutics PLCADAPBARRIS PETER J
10% owner
15,000,000$1.67$25,050,000
2018-09-07
Purchase
Adaptimmune Therapeutics PLCADAPBASKETT FOREST
10% owner
15,000,000$1.67$25,050,000
2018-09-07
Purchase
Adaptimmune Therapeutics PLCADAPBehbahani Ali
Director
12,000,000$1.67$20,040,000
2018-09-07
Purchase
Adaptimmune Therapeutics PLCADAPFlorence Anthony A. Jr.
10% owner
15,000,000$1.67$25,050,000
2018-09-07
Purchase
Adaptimmune Therapeutics PLCADAPKERINS PATRICK J
10% owner
3,000,000$1.67$5,010,000
2018-09-07
Purchase
Adaptimmune Therapeutics PLCADAPMOTT DAVID M
Director, 10% owner
15,000,000$1.67$25,050,000
2018-09-07
Purchase
Adaptimmune Therapeutics PLCADAPSANDELL SCOTT D
10% owner
15,000,000$1.67$25,050,000
2018-09-07
Purchase
Adaptimmune Therapeutics PLCADAPSonsini Peter W.
10% owner
15,000,000$1.67$25,050,000
2018-09-07
Purchase
Adaptimmune Therapeutics PLCADAPViswanathan Ravi
10% owner
15,000,000$1.67$25,050,000

1 2 3 4 Next >

*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*